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To the editor,
   The newest emerging influenza which has just been 
reported in November 2013 from Taiwan province is the 
H6N1 bird flu. This infection is the emerging zoonotic 
influenza which crosses species from avian to human 
beings[1,2]. The first indexed case in Taiwan presented 
with acute respiratory illness, which is concordant with 
the clinical feature of acute influenza infection[1,2]. 
The final confirmation of the new emerging influenza 
H6N1 bird flu is due to the virological examination. The 
interesting topic is that this new infection has the same 
clinical features as the simple influenza infection[3]. 
There is no atypical presentation (no gastrointestinal, 
ocular, neurological and other signs and symptoms)[3]. 
Focusing on the laboratory findings, the H6N1 bird flu 
shows no abnormality of liver function, renal function 
and other blood biochemical parameters[3]. For the 
hematological aberration, only the slightly increased 
white blood cell count, which is different from general 
influenza infection, can be observed[3]. It can be said 
that the clinical features of the new emerging H6N1 
influenza infection is mild and might be difficult to 
be differentiated from general influenza. Perhaps, the 
human infection might exist for a long time, but it 
has never been detected by confirmative virological 
examination. Nevertheless, since it has just been 
the starting phase of discovery of the new infection, 
further information from further reports is needed for 
summative conclusion of the clinical presentation of the 
new emerging H6N1 bird flu.  
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